These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35776660)

  • 21. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling.
    Winkler M; Staniczek T; Kürschner SW; Schmid CD; Schönhaber H; Cordero J; Kessler L; Mathes A; Sticht C; Neßling M; Uvarovskii A; Anders S; Zhang XJ; von Figura G; Hartmann D; Mogler C; Dobreva G; Schledzewski K; Géraud C; Koch PS; Goerdt S
    J Hepatol; 2021 Feb; 74(2):380-393. PubMed ID: 32916216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood flow regulates
    Anzell AR; Kunz AB; Donovan JP; Tran TG; Lu X; Young S; Roman BL
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonfunctional TGF-β/ALK1/ENG signaling pathway supports neutrophil proangiogenic activity in hereditary hemorrhagic telangiectasia.
    Duerig I; Pylaeva E; Ozel I; Wainwright S; Thiel I; Bordbari S; Domnich M; Siakaeva E; Lakomek A; Toppe F; Schleupner C; Geisthoff U; Lang S; Droege F; Jablonska J
    J Leukoc Biol; 2023 Nov; 114(6):639-650. PubMed ID: 37555392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations.
    Gkatzis K; Thalgott J; Dos-Santos-Luis D; Martin S; Lamandé N; Carette MF; Disch F; Snijder RJ; Westermann CJ; Mager JJ; Oh SP; Miquerol L; Arthur HM; Mummery CL; Lebrin F
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):707-17. PubMed ID: 26821948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
    Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.
    Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM
    Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
    Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
    Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
    Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALK1 signaling in development and disease: new paradigms.
    Roman BL; Hinck AP
    Cell Mol Life Sci; 2017 Dec; 74(24):4539-4560. PubMed ID: 28871312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.
    Larrivée B; Prahst C; Gordon E; del Toro R; Mathivet T; Duarte A; Simons M; Eichmann A
    Dev Cell; 2012 Mar; 22(3):489-500. PubMed ID: 22421041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
    Seki T; Yun J; Oh SP
    Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms.
    Arthur HM; Roman BL
    Front Med (Lausanne); 2022; 9():973964. PubMed ID: 36250069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
    Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
    Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BMP9 and BMP10: Two close vascular quiescence partners that stand out.
    Desroches-Castan A; Tillet E; Bouvard C; Bailly S
    Dev Dyn; 2022 Jan; 251(1):178-197. PubMed ID: 34240497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the ALK1 ligands, BMP9 and BMP10.
    Li W; Salmon RM; Jiang H; Morrell NW
    Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Microphysiological HHT-on-a-Chip Platform Recapitulates Patient Vascular Lesions.
    Fang JS; Hatch CJ; Andrejecsk J; Trigt WV; Juat DJ; Chen YH; Matsumoto S; Lee AP; Hughes CCW
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2.
    Srinivasan S; Hanes MA; Dickens T; Porteous ME; Oh SP; Hale LP; Marchuk DA
    Hum Mol Genet; 2003 Mar; 12(5):473-82. PubMed ID: 12588795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.